Healthy Patients

Antimicrobial resistance (AMR)

AMR develops when bacteria, fungi or viruses are exposed to antibiotics, antifungals or antivirals. As a result, the antimicrobials become ineffective and infections may persist. In addition, medical interventions including surgery, chemotherapy and stem cell therapy may become impossible.
AMR is considered the biggest global threat of Health and Food Safety.

AMR Insights

For Healthcare professionals who wish to prevent Antimicrobial resistance, AMR Insights offers selected, global information and data, specific education and extensive networking and partnering opportunities.

AMR Insights is for:

  • Medical Microbiologists, Infectiologists and other specialists
  • General Practitioners, Pharmacists
  • Infection Prevention Experts and nurses
  • Medical Docters and Caretakers in nursing homes
  • Managers and Labtechnicians of Microbiological Laboratories.

Latest Topics

  •   15 March 2024

    Microbiological Characteristics and Resistance Patterns in a Neonatal Intensive Care Unit: A Retrospective Surveillance Study

    This study examines the prevalence and antimicrobial susceptibility patterns of bacterial infections in neonates with early-onset sepsis (EOS) and late-onset sepsis (LOS). Results show LOS has a higher incidence (94.43%) compared to EOS (5.56%). The leading isolates are gram-positive bacteria, with coagulase-negative Staphylococci (CONS) being predominant in LOS cases (42.9%). The study found reduced resistance […]

    Read more...
  •   15 March 2024

    The causes of bacterial bloodstream infections and antimicrobial resistance patterns in children attending a secondary care hospital in Bhaktapur, Nepal, 2017–2022: a retrospective study

    This study analyzed the causes of bacterial bloodstream infections (BSIs) among children in Nepal, focusing on antimicrobial resistance patterns and β-lactamase production in Enterobacterales. The study found that Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii complex were the most common BSIs in neonates. In non-neonates, 275/285 infections were community-acquired, with 29.6% being methicillin-resistant Staphylococcus aureus. […]

    Read more...
  •   14 March 2024

    WHO AWaRe Antibiotic Book

    The World Health Organization AWaRe Antibiotic book is a new gold standard resource to help countries fight against antimicrobial resistance (AMR), guiding health professionals to select the best antibiotics for their patients. Firstline has partnered with the WHO to give health professionals in every country, free access to the very best antibiotic prescribing knowledge, for […]

    Read more...

More news related to Healthy patients

Please call me back

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed